Get the Stockscreener App
2.155
5.05%
-0.115
After Hours:
2.17
0.015
+0.70%
Allogene Therapeutics Inc Stock (ALLO) Forecast
The Allogene Therapeutics Inc (ALLO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.0302, representing a +87.02% increase from the current price of $2.155. The highest analyst price target is $6.8488, and the lowest is $1.2116.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ALLO Price Target
Average 16.66
(+673.04% Upside)
Is Allogene Therapeutics Inc (ALLO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.83 | Neutral |
| STOCH(9,6) | 20.80 | Neutral |
| STOCHRSI(14) | 26.52 | Neutral |
| MACD(12,26) | -0.0643 | Sell |
| ADX(14) | 17.94 | Neutral |
| William %R | -98.77 | Buy |
| CCI(14) | -167.49 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.8015
Sell
|
2.6214
Sell
|
| MA20 |
2.748
Sell
|
2.706
Sell
|
| MA50 |
2.744
Sell
|
2.7195
Sell
|
| MA100 |
2.6816
Sell
|
2.766
Sell
|
| MA200 |
3.151
Sell
|
2.9353
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ALLO could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ALLO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.83 indicates that ALLO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 20.8 indicates that ALLO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.52 indicates that ALLO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.94 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -167.49 indicates that ALLO is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ALLO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Allogene Therapeutics Inc financial reports and earnings history, Allogene Therapeutics Inc (ALLO) stock could reach $26.20 by 2030, $19.16 by 2040 and $58.69 by 2050. See the projected annual prices until 2050 of the Allogene Therapeutics Inc stock below:
- Allogene Therapeutics Inc (ALLO) is expected to reach an average price of $7.1436 in 2035, with a high prediction of $7.8061 and a low estimate of $7.2636. This indicates an $231.49% rise from the last recorded price of $2.155.
- Allogene Therapeutics Inc (ALLO) stock is projected to chart a bullish course in 2040, with an average price target of $18.12, representing an $740.78% surge from its current level. The forecast ranges from a conservative $18.39 to a sky-high $19.16.
- Our analysts predict Allogene Therapeutics Inc (ALLO) to jump 1,391% by 2045, soaring from $30.20 to an average price of $32.13, potentially reaching $30.95. While $30.20 is the low estimate, the potential upside is significant.
- Allogene Therapeutics Inc (ALLO) stock is expected to climb by 2050, reaching an average of $57.23, a $2,555% jump from its current level. However, a wide range of estimates exists, with high and low targets of $58.69 and $59.21, respectively, highlighting the market's uncertainty.
Allogene Therapeutics Inc Stock (ALLO) Year by Year Forecast
Allogene Therapeutics Inc Stock (ALLO) Price Forecast for 2024
Our forecast for ALLO stock price in 2024 now indicates an average price target of $4.0801 with a high forecast of $8.131 and a low forecast of $0.0292. The average prediction reflects an increase of +89.33% from the last recorded price of $2.155.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $6.7638 | $1.2116 | $6.8488 | +213.86% |
Allogene Therapeutics Inc Stock (ALLO) Price Forecast for 2025
Allogene Therapeutics Inc Stock (ALLO) is expected to reach an average price of $16.66 in 2025, with a high prediction of $32.71 and a low estimate of $0.6038. This indicates an +673.04% rise from the last recorded price of $2.155.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.759 | $1.06 | $8.8978 | -18.37% |
| February, 2025 | $2.2298 | $0.6038 | $3.6512 | +3.47% |
| March, 2025 | $3.1965 | $0.6826 | $3.7865 | +48.33% |
| April, 2025 | $3.6233 | $2.9154 | $4.7905 | +68.13% |
| May, 2025 | $4.9929 | $0.6111 | $7.1829 | +131.69% |
| June, 2025 | $22.52 | $3.657 | $23.83 | +944.97% |
| July, 2025 | $18.08 | $17.64 | $32.71 | +738.95% |
| August, 2025 | $21.19 | $17.89 | $25.22 | +883.09% |
| September, 2025 | $16.33 | $14.47 | $22.35 | +657.86% |
| October, 2025 | $12.15 | $10.73 | $18.23 | +463.90% |
| November, 2025 | $17.17 | $10.97 | $17.65 | +696.67% |
| December, 2025 | $13.80 | $13.53 | $24.63 | +540.31% |
Allogene Therapeutics Inc Stock (ALLO) Price Forecast for 2026
The predicted value for Allogene Therapeutics Inc (ALLO) in 2026 is set at an average of $12.46. Estimates vary from a peak of $20.76 to a trough of $4.1569, indicating an +478.15% surge from the present price of $2.155.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.73 | $7.4226 | $14.59 | +444.54% |
| February, 2026 | $7.711 | $7.176 | $14.24 | +257.82% |
| March, 2026 | $13.32 | $5.6532 | $14.53 | +517.97% |
| April, 2026 | $16.03 | $11.40 | $19.58 | +643.74% |
| May, 2026 | $18.65 | $13.08 | $20.76 | +765.60% |
| June, 2026 | $14.80 | $14.17 | $20.14 | +586.77% |
| July, 2026 | $9.9002 | $8.7602 | $18.11 | +359.41% |
| August, 2026 | $8.8364 | $6.0364 | $14.25 | +310.04% |
| September, 2026 | $7.2567 | $6.0145 | $10.16 | +236.74% |
| October, 2026 | $6.9329 | $4.5088 | $7.9892 | +221.71% |
| November, 2026 | $7.6791 | $4.1569 | $8.745 | +256.34% |
| December, 2026 | $9.9694 | $7.6731 | $12.03 | +362.62% |
Allogene Therapeutics Inc Stock (ALLO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Allogene Therapeutics Inc (ALLO) is $5.0039, with a high forecast of $9.9934 and a low forecast of $0.0143. This indicates an +132.20% increase from the last price of $2.155.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4256 | $0.0143 | $9.9934 | -80.25% |
| February, 2027 | $3.7318 | $0.0304 | $5.5037 | +73.17% |
| March, 2027 | $1.1521 | $1.4079 | $4.4239 | -46.54% |
| April, 2027 | $1.0417 | $0.3902 | $1.7102 | -51.66% |
| May, 2027 | $2.9655 | $2.8777 | $2.5696 | +37.61% |
| June, 2027 | $5.5253 | $3.8115 | $4.4253 | +156.39% |
| July, 2027 | $4.119 | $3.9731 | $4.6012 | +91.14% |
| August, 2027 | $5.0928 | $4.045 | $4.6228 | +136.33% |
| September, 2027 | $4.4726 | $4.6346 | $4.8666 | +107.54% |
| October, 2027 | $1.1763 | $3.7262 | $4.0885 | -45.41% |
| November, 2027 | $0.2299 | $0.6742 | $0.5399 | -89.33% |
| December, 2027 | $5.8701 | $0.4161 | $6.1101 | +172.40% |
Allogene Therapeutics Inc Stock (ALLO) Price Forecast for 2028
In 2028, Allogene Therapeutics Inc (ALLO) is projected to reach an average price of $3.0666, with a high projection of $6.0942 and a low estimate of $0.039. This indicates an +42.30% rise from the last price of $2.155.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.1563 | $2.2623 | $6.0942 | +46.47% |
| February, 2028 | $0.0926 | $0.5324 | $4.5954 | -95.70% |
| March, 2028 | $0.0128 | $0.1272 | $1.5866 | -99.40% |
| April, 2028 | $0.819 | $0.039 | $1.149 | -61.99% |
| May, 2028 | $3.5707 | $0.7569 | $2.5857 | +65.69% |
| June, 2028 | $2.6445 | $3.1145 | $3.1466 | +22.71% |
| July, 2028 | $1.9883 | $1.3723 | $1.0583 | -7.74% |
| August, 2028 | $2.738 | $2.0342 | $2.2594 | +27.05% |
| September, 2028 | $3.2118 | $3.0539 | $2.9558 | +49.04% |
| October, 2028 | $1.1656 | $2.4806 | $2.8077 | -45.91% |
| November, 2028 | $1.7353 | $1.6515 | $1.7594 | -19.48% |
| December, 2028 | $2.0391 | $1.8563 | $2.2181 | -5.38% |
Allogene Therapeutics Inc Stock (ALLO) Price Forecast for 2029
The 2029 price forecast for Allogene Therapeutics Inc Stock (ALLO) is $11.86 on average, with a high prediction of $23.71 and a low estimate of $0.0176. This represents an +450.53% increase from the previous price of $2.155.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6288 | $1.6988 | $1.5903 | -24.42% |
| February, 2029 | $2.3826 | $1.9348 | $2.2276 | +10.56% |
| March, 2029 | $2.0264 | $2.0864 | $2.1936 | -5.97% |
| April, 2029 | $2.3902 | $2.2023 | $2.4637 | +10.91% |
| May, 2029 | $2.6599 | $2.509 | $2.478 | +23.43% |
| June, 2029 | $2.3037 | $2.2718 | $2.2737 | +6.90% |
| July, 2029 | $1.2775 | $1.5675 | $2.0497 | -40.72% |
| August, 2029 | $0.5472 | $0.9472 | $0.9053 | -74.61% |
| September, 2029 | $0.809 | $0.0491 | $1.2649 | -62.46% |
| October, 2029 | $0.9493 | $0.8093 | $2.2961 | -55.95% |
| November, 2029 | $0.4955 | $0.4055 | $1.4033 | -77.01% |
| December, 2029 | $24.43 | $0.0176 | $23.71 | +1,034% |
Allogene Therapeutics Inc Stock (ALLO) Price Forecast for 2030
Allogene Therapeutics Inc Stock (ALLO) is expected to reach an average price of $23.36 in 2030, with a high forecast of $26.38 and a low forecast of $20.34. This signifies an +984.04% surge from the last price of $2.155.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $27.14 | $26.74 | $26.20 | +1,159% |
| February, 2030 | $26.78 | $26.85 | $26.38 | +1,143% |
| March, 2030 | $22.82 | $23.50 | $24.37 | +958.91% |
| April, 2030 | $24.84 | $24.20 | $24.35 | +1,053% |
| May, 2030 | $23.66 | $21.87 | $23.17 | +997.99% |
| June, 2030 | $21.17 | $22.84 | $23.13 | +882.33% |
| July, 2030 | $22.59 | $21.55 | $21.54 | +948.20% |
| August, 2030 | $21.92 | $21.21 | $20.98 | +917.23% |
| September, 2030 | $21.99 | $22.66 | $22.04 | +920.60% |
| October, 2030 | $23.62 | $22.73 | $24.33 | +996.21% |
| November, 2030 | $25.24 | $20.34 | $20.95 | +1,071% |
| December, 2030 | $27.15 | $27.36 | $26.06 | +1,160% |
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):